Journal ArticleJournal of Clinical Oncology · June 1, 2024
e19507 Background: Belamaf is an anti-B cell maturation antigen immunoconjugate for relapsed/refractory multiple myeloma that has shown efficacy and safety in the DREAMM clinical trials. Additional long-term real-world data on it ...
Full textCite
Journal ArticleJournal of Curriculum and Teaching · January 1, 2024
This is the first in a multi-part series on teaching statistical inference to physician-scientists training to work as members of interdisciplinary scientific teams. This unique student audience has greater scientific sophistication than a typical statisti ...
Full textCite
